Bioventus
BVS
BVS
148 hedge funds and large institutions have $373M invested in Bioventus in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 37 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.45% more ownership
Funds ownership: 73.51% → 74.96% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
148
Holding in Top 10
3
Calls
$881K
Puts
–
Top Buyers
| 1 | +$2.79M | |
| 2 | +$2.27M | |
| 3 | +$1.94M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.22M |
Top Sellers
| 1 | -$3.68M | |
| 2 | -$1.75M | |
| 3 | -$1.41M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.06M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$547K |
